Neuburgh Advisers’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $2.03M | Buy |
27,654
+3,630
| +15% | +$266K | 0.06% | 223 |
|
|
2019
Q2 | $1.48M | Buy |
24,024
+3,630
| +18% | +$223K | 0.05% | 271 |
|
|
2019
Q1 | $1.3M | Buy |
20,394
+2,640
| +15% | +$168K | 0.04% | 254 |
|
|
2018
Q4 | $906K | Buy |
17,754
+1,848
| +12% | +$94.3K | 0.04% | 281 |
|
|
2018
Q3 | $923K | Sell |
15,906
-198
| -1% | -$11.5K | 0.03% | 317 |
|
|
2018
Q2 | $782K | Buy |
16,104
+924
| +6% | +$44.9K | 0.03% | 327 |
|
|
2018
Q1 | $706K | Sell |
15,180
-1,320
| -8% | -$61.4K | 0.02% | 335 |
|
|
2017
Q4 | $620K | Buy |
16,500
+3,828
| +30% | +$144K | 0.02% | 374 |
|
|
2017
Q3 | $462K | Sell |
12,672
-6,798
| -35% | -$248K | 0.02% | 410 |
|
|
2017
Q2 | $768K | Sell |
19,470
-10,362
| -35% | -$409K | 0.03% | 319 |
|
|
2017
Q1 | $935K | Sell |
29,832
-60,258
| -67% | -$1.89M | 0.04% | 276 |
|
|
2016
Q4 | $2.81M | Buy |
+90,090
| New | +$2.81M | 0.13% | 140 |
|